Changes in cardiovascular function on treatment of inhibitors of apoptotic signal transduction pathways in left ventricular remodeling after myocardial infarction

Cardiovascular Pathology

Volumn 15, Issue 3, 2006, Pages 130-138

  Saitoh, Tadashi ^a   Nakajima, Takayuki ^b   Takahashi, Tatsuhisa ^c   Kawahara, Koichi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Osaka Prefecture University   (Japan)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Apoptosis; Cardiovascular function; Left ventricular remodeling

Indexed keywords

APOPTOSIS INHIBITOR; CALPASTATIN; CASPASE 3 INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY PRESSURE; DRUG EFFECT; HEART INFARCTION; HEART RATE; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE; TISSUE SECTION; TREATMENT OUTCOME;

EID: 33646343433     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2006.01.003     Document Type: Article

References (41)

1. Mann D. Mechanisms and models in heart failure: a combinatorial approach. Circulation 100 (1999) 999-1008
2. Cohn J., Ferrari R., and Sharpe N. Cardiac remodeling - concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol 35 (2000) 569-582
3. Preffer M., and Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 81 (1990) 1161-1172
4. Sutton M., and Sharpe N. Left ventricular remodeling after myocardial infarction - pathophysiology and therapy. Circulation 101 (2000) 2981-2988
5. Elsasser A., Suzuki K., and Schaper J. Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure. J Mol Cell Cardiol 32 (2000) 711-724
6. Wyllie A. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284 (1980) 555-556
7. Sam F., Sawyer D., Chang D.-F., Eberli F., Ngoy S., Jain M., Amin J., Apstein C., and Colucci W. Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am J Physiol Heart Circ Physiol 279 (2000) H422-H428
8. Baldi A., Abbate A., Bussani R., Patti G., Melfi R., Angelini A., Dobrina A., Rossiello R., Silvestri F., Baldi F., and Sciascio G. Apoptosis and post-infarction left ventricular remodeling. J Mol Cell Cardiol 34 (2002) 165-174
9. Abbate A., Biondi-Zoccai G., Bussani R., Dobrina A., Camilot D., Feroce F., Rossiello R., Baldi F., Silvestri F., Biasucci L., and Baldi A. Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. J Am Coll Cardiol 41 (2003) 753-760
10. Palojoki E., Saraste A., Eriksson A., Pulkki K., Kallajoki M., Voipio-Pulkki L., and Tikkanen I. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol 280 (2001) H2726-H2731
11. Saitoh T., Nakajima T., and Kawahara K. Possible involvement of apoptotic death of myocytes in left ventricular remodeling after myocardial infarction. Jpn J Physiol 53 (2003) 247-252
12. Anand I., Liu D., Chugh S., Prahash A., Gupta S., John R., Popescu F., and Chandrashekhar Y. Isolated myocyte contractile function is normal in postinfarct remodeled rat heart with systolic dysfunction. Circulation 96 (1997) 3974-3984
13. Raya T., Gaballa M., and Goldman S. Left ventricular function and remodeling after myocardial infarction in aging rats. Am J Physiol Heart Circ Physiol 42 (1997) H2652-H2658
14. Bosi G., Crepaz R., Gamberini M., Fortini M., Scarcia S., Bonsante E., Pitscheider W., and Vaccari M. Left ventricular remodeling, and systolic and diastolic function in young adults with β thalassaemia major: a Doppler echocardiographic assessment and correlation with haematological data. Heart 89 (2003) 762-766
15. Yaoita H., Ogawa K., Maehara K., and Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation 97 (1998) 276-281
16. Perrin C., Ecarnot-Laubriet A., Vergely C., and Rochette L. Calpain and caspase-3 inhibitors reduce infarct size and post-ischemic apoptosis in rat heart without modifying contractile recovery. Cell Mol Biol 49 (2003) OL497-OL505 [Online]
17. Bock-Marquette I., Saxena A., White M., DiMaio J., and Srivastava D. Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432 (2004) 466-472
18. f current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation 109 (2004) 1674-1679
19. Chandrashekhar Y., Sen S., Anway R., Shuros A., and Anand I. Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction. J Am Coll Cardiol 43 (2004) 295-301
20. Kouchi Z., Saido T., Ohyama H., Maruta H., Suzuki K., and Tanuma S. The restrictive proteolysis of α-fodrin to a 120 kDa fragment is not catalyzed by calpains during thymic apoptosis. Apoptosis 2 (1997) 84-90
21. Wang K. Calpain and caspase: can you tell the difference?. Trends Neurosci 23 (2000) 20-26
22. Nelson R., Gobel F., Jorgensen C., Wang K., Wang Y., and Taylor H. Hemodynamic predictions of myocardial oxygen consumption during static and dynamic exercise. Circulation 50 (1974) 1179-1189
23. Olivetti G., Capasso J., Meggs L., Sonnenblick E., and Anversa P. Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res 68 (1991) 856-869
24. Fung Y. Biodynamics: circulation (1984), Springer-Verlag, New York 22-76
25. Sakahira H., Enari M., and Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391 (1998) 96-99
26. Nicholson D., Ali A., Thornberry N., Vaillancourt J., Ding C., Gallant M., Gareau Y., Griffin P., Labelle M., Lazebnik Y., Munday N., Raju S., Smulson M., Yamin T.-T., Yu V., and Miller D. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376 (1995) 37-43
27. Tewari M., Quan L., O'Rourke K., Desnoyers S., Zeng Z., Beidler D., Poirier G., Salvesen G., and Dixit V. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81 (1995) 801-809
28. Nagata S. Apoptosis by death factor. Cell 88 (1997) 355-365
29. Yaoita H., Ogawa K., Maehara K., and Maruyama Y. Apoptosis in relevant clinical situations: contribution of apoptosis in myocardial infarction. Cardiovasc Res 45 (2000) 630-641
30. Chua B., Guo K., and Li P. Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases. J Biol Chem 275 (2000) 5131-5135
31. Sandmann S., Prenzel F., Shaw L., Schauer R., and Unger T. Activity profile of calpains I and II in chronically infarcted rat myocardium - influence of the calpain inhibitor CAL 9961. Br J Pharmacol 135 (2002) 1951-1958
32. Neumar R., Xu Y., Gada H., Guttmann R., and Siman R. Cross-talk between calpain and caspase proteolytic systems during neuronal apoptosis. J Biol Chem 278 (2003) 14162-14167
33. Gill C., Mestril R., and Samali A. Losing heart: the role of apoptosis in heart disease - a novel therapeutic target?. FASEB J 16 (2002) 135-146
34. Wolf B., Schuler M., Echeverri F., and Green D. Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation. J Biol Chem 274 (1999) 30651-30656
35. Ruiz-Vela A., de Buitrago G., and Martinez C. Implication of calpain in caspase activation during B cell clonal deletion. EMBO J 18 (1999) 4988-4998
36. 2+-calpain and caspase-mitochondria-dependent pathways. J Biol Chem 275 (2000) 39702-39709
37. Nakagawa T., and Yuan J. Cross-talk between two cysteine protease families: activation of caspase-12 by calpain in apoptosis. J Cell Biol 150 (2000) 887-894
38. Altznauer F., Conus S., Cavalli A., Folkers G., and Simon H. Calpain-1 regulates Bax and subsequent Smac-dependent caspase-3 activation in neutrophil apoptosis. J Biol Chem 279 (2004) 5947-5957
39. Janicke R., Ng P., Sprengart M., and Porter A. Caspase-3 is required for α-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J Biol Chem 273 (1998) 15540-15545
40. Ruetten H., Badorff C., Ihling C., Zeiher A., and Dimmeler S. Inhibition of caspase-3 improves contractile recovery of stunned myocardium, independent of apoptosis-inhibitory effects. J Am Coll Cardiol 38 (2001) 2063-2070
41. Okamura T., Miura T., Takemura G., Fujiwara H., Iwamoto H., Kawamura S., Kimura M., Ikeda Y., Iwatate M., and Matsuzaki M. Effect of caspase inhibitors on myocardial infarct size and myocyte DNA fragmentation in the ischemia-reperfused rat heart. Cadiovasc Res 45 (2000) 642-650